Lena Gorgannezhad
Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies.
Gorgannezhad, Lena; Umer, Muhammad; Islam, Md. Nazmul; Nguyen, Nam-Trung; Shiddiky, Muhammad J.A.
Authors
Contributors
Gorgannezhad, Lena
Other
Umer, Muhammad
Other
Islam, Md Nazmul
Other
Nguyen, Nam-Trung
Other
Shiddiky, Muhammad J A
Other
Abstract
Cell-free DNA (cfDNA) refers to short fragments of acellular nucleic acids detectable in almost all body fluids, including blood, and is involved in various physiological and pathological phenomena such as immunity, coagulation, aging, and cancer. In cancer patients, a fraction of hematogenous cfDNA originates from tumors, termed circulating tumor DNA (ctDNA), and may carry the same mutations and genetic alterations as those of a primary tumor. Thus, ctDNA potentially provides an opportunity for noninvasive assessment of cancer. Recent advances in ctDNA analysis methods will potentially lead to the development of a liquid biopsy tool for the diagnosis, prognosis, therapy response monitoring, and tracking the rise of new mutant sub-clones in cancer patients. Over the past few decades, cancer-specific mutations in ctDNA have been detected using a variety of untargeted methods such as digital karyotyping, personalized analysis of rearranged ends (PARE), whole-genome sequencing of ctDNA, and targeted approaches such as conventional and digital PCR-based methods and deep sequencing-based technologies. More recently, several chip-based electrochemical sensors have been developed for the analysis of ctDNA in patient samples. This paper aims to comprehensively review the diagnostic, prognostic, and predictive potential of ctDNA as a minimally invasive liquid biopsy for cancer patients. We also present an overview of current advances in the analytical sensitivity and accuracy of ctDNA analysis methods as well as biological and technical challenges, which need to be resolved for the integration of ctDNA analysis into routine clinical practice.
Citation
Gorgannezhad, L., Umer, M., Islam, M. N., Nguyen, N.-T., & Shiddiky, M. J. (2018). Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies. Lab on a Chip, https://doi.org/10.1039/C8LC00100F
Journal Article Type | Article |
---|---|
Acceptance Date | Mar 12, 2018 |
Online Publication Date | Mar 13, 2018 |
Publication Date | Mar 13, 2018 |
Deposit Date | Jun 24, 2025 |
Journal | Lab on a chip |
Print ISSN | 1473-0197 |
Electronic ISSN | 1473-0189 |
Publisher | Royal Society of Chemistry |
Peer Reviewed | Peer Reviewed |
Issue | 8 |
DOI | https://doi.org/10.1039/C8LC00100F |
Public URL | https://keele-repository.worktribe.com/output/1053988 |
Publisher URL | https://pubs.rsc.org/en/content/articlelanding/2018/lc/c8lc00100f |
You might also like
Nucleic acid sensing via electrochemical oligonucleotide-templated reactions
(2020)
Journal Article
Hydrogel Nanoarchitectonics
(2022)
Journal Article
Chapter 1.3 - Electrochemical sensors
(2019)
Book Chapter
An amplification-free electrochemical detection of exosomal miRNA-21 in serum samples
(2018)
Journal Article
Downloadable Citations
About Keele Repository
Administrator e-mail: research.openaccess@keele.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search